uterine cancer	is a	gynecologic cancer
uterine cancer	arises_from	endometrium
endometrium	is_site_of	endometrial cancer
endometrial cancer	has_histology	endometrioid adenocarcinoma
endometrial cancer	has_histology	serous carcinoma
endometrial cancer	has_histology	clear cell carcinoma
endometrial cancer	has_histology	squamous differentiation
endometrial cancer	has_histology	undifferentiated carcinoma
endometrial cancer	has_histology	mucinous carcinoma
obesity	increases_risk_of	endometrial cancer
unopposed estrogen	increases_risk_of	endometrial cancer
tamoxifen use	increases_risk_of	endometrial cancer
nulliparity	increases_risk_of	endometrial cancer
early_menarche	increases_risk_of	endometrial cancer
late menopause	increases_risk_of	endometrial cancer
polycystic ovary syndrome	increases_risk_of	endometrial cancer
diabetes mellitus	increases_risk_of	endometrial cancer
hypertension	increases_risk_of	endometrial cancer
age over 50	increases_risk_of	endometrial cancer
abnormal_vaginal_bleeding	presents_with	endometrial cancer
postmenopausal_bleeding	presents_with	endometrial cancer
pelvic_pain	presents_with	endometrial cancer
transvaginal ultrasound	used_for	assessment_of_endometrial_thickness
endometrial_sampling	diagnostic_for	endometrial cancer
endometrial_biopsy	confirms	endometrial cancer
hysteroscopy	used_for	endometrial cancer diagnosis
MRI	used_for	staging_of_endometrial_cancer
CT scan	used_for	metastasis_assessment_endometrial_cancer
PET CT	used_for	metastatic_workup_endometrial_cancer
uterine cancer	treated_with	hysterectomy
endometrial cancer	treated_with	hysterectomy
endometrial cancer	treated_with	radiotherapy
endometrial cancer	treated_with	chemotherapy
endometrial cancer	treated_with	progestin_therapy
hormone receptor status	guides_treatment_in	endometrial cancer
PTEN mutation	common_in	endometrioid_endometrial_cancer
p53 mutation	associated_with	serous_endometrial_carcinoma
MSI high	associated_with	endometrial_cancer
ARID1A mutation	observed_in	endometrial cancer
POLE mutation	observed_in	endometrial cancer
HER2 overexpression	observed_in	uterine_serous_endometrial_carcinoma
ER expression	correlates_with	endometrial cancer
PR expression	correlates_with	endometrial cancer
early stage endometrial_cancer	prognosis_better	survival
high_grade_endometrial_cancer	prognosis_worse	survival
advanced_stage_endometrial_cancer	prognosis_worse	survival
lymph_node_metastasis	indicates_poor_prognosis	endometrial cancer
lymphovascular_space_invasion	risk_factor_for	metastasis_in_endometrial_cancer
deep_myometrial_invasion	indicates_poor_prognosis	endometrial cancer
surgical_margins	prognostic_for	endometrial cancer
recurrence_after_surgery	occurs_in	endometrial cancer
Lynch_syndrome	predisposes_to	endometrial cancer
family_history_of_gyn_cancer	increases_risk_of	endometrial cancer
metabolic_syndrome	increases_risk_of	endometrial cancer
parity	protective_against	endometrial cancer
lymph_node_involvement	indicates_poor_prognosis	endometrial cancer
surgical_staging	provides_accurate_staging	endometrial_cancer
tumor_grade	influences_treatment_decision	endometrial cancer
tumor_stage	influences_treatment_decision	endometrial cancer
myometrial_invasion	assessed_for	prognosis_of_endometrial_cancer
lymphovascular_invasion	is_warning_sign_for	recurrence_of_endometrial_cancer
deep_myometrial_invasion	indicates_poor_prognosis	endometrial_cancer
Lynch_syndrome	linked_with	MSI_high_endometrial_cancer
surgical_margin_status	impacts_postoperative_outcome	endometrial_cancer
adjuvant_therapy	recommended_for	high_risk_endometrial_cancer
endometrial_cancer_subtype	determines_therapy	endometrial_cancer
protein_expression_profile	guides_targeted_therapy	endometrial_cancer
targeted_therapy	used_for	certain_endometrial_cancer_subtypes
trastuzumab	used_for	HER2_positive_endometrial_cancer
p53_overexpression	marker_of	high_grade_endometrial_cancer
disease_free_survival	depends_on	stage_at_diagnosis
overall_survival	correlates_with	tumor_stage
recurrence_pattern	differs_by	histologic_subtype
treatment_toxicity	includes	anemia
genomic_signature	used_for	prognosis_in_endometrial_cancer
cytology_screening	screening_for	endometrial_cancer
hysterectomy_complications	occur_in	endometrial_cancer_surgery
surveillance_imaging	used_for	post_treatment_follow_up_endometrial_cancer
lymph_node_dissection	part_of	surgical_staging_for_endometrial_cancer
adjuvant_radiation	reduces_local_recurrence	endometrial_cancer
intracavitary_radiation	delivered_as	brachytherapy_for_endometrial_cancer
neoadjuvant_therapy	considered_for	bulky_endometrial_cancer
clinical_trial_enrollment	offered_for	new_endometrial_cancer_treatments
HER2_status	guides	targeted_therapy_in_endometrial_cancer
mismatch_repair_deficiency	leads_to	MSI_high_endometrial_cancer
POLE_mutation	associated_with	ultramutated_endometrial_cancer
ARID1A_mutation	associated_with	endometrial_cancer_subtypes
PTEN_mutation	associated_with	endometrioid_subtype
tumor_mutational_burden	correlates_with	prognosis_in_endometrial_cancer
circulating_tumor_cells	indicate_progression	endometrial_cancer
performance_status	influences_treatment_decision	endometrial_cancer
obesity_management	improves_outcomes	endometrial_cancer_treatment
estrogen_receptor_status	predicts_response_to	progestin_therapy_in_endometrial_cancer
endometrial_cancer_subtypes	show_different_imaging_features	MRI
tumor_size_at_diagnosis	correlates_with	prognosis_in_endometrial_cancer
survivorship_needs	follow_up_after_treatment	endometrial_cancer
surgical_closure	affects_postoperative_pain	endometrial_cancer_surgery
reconstructive_procedure	may_follow	hysterectomy_for_endometrial_cancer
immunotherapy	role_in	dMMR_endometrial_cancer
circulating_dna	used_for	monitoring_endometrial_cancer
nutritional_status	influences_treatment_tolerance	endometrial_cancer
